Back
Unity Software Vs. Keros Therapeutics Industry Stock Comparison
Sell
49
U
Unity Software
Last Price:
25.33
Seasonality Move:
18.43%
Sell
43
KROS
Keros Therapeutics
Last Price:
58.60
Seasonality Move:
-7.87%
Sell
49
Unity Software (U)
is a Sell
Is Unity Software a Buy, Sell or Hold?
- The current Unity Software [U] share price is $25.32. The Score for U is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- U is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $58.68. The Score for KROS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
U Stock Price Chart
What is Unity Software's stock price today?
-
The Unity Software share price today is $25.32
The current trend is relatively stagnant and U is experiencing slight selling pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $58.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.
U Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.37 | Sell |
| Relative Strength Index (14 RSI): | 52.24 | Buy |
| Chaikin Money Flow: | -1509913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.53 - 25.75) | Buy |
| Bollinger Bands (100): | (25.24 - 36.06) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.96 | Sell |
| Relative Strength Index (14 RSI): | 48 | Sell |
| Chaikin Money Flow: | -62859 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.46 - 61.76) | Sell |
| Bollinger Bands (100): | (46.93 - 66.27) | Buy |
U Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.71 | Buy |
| 20-day SMA: | 24.31 | Buy |
| 50-day SMA: | 25.91 | Sell |
| 200-day SMA: | 31.69 | Sell |
| 8-day EMA: | 24.73 | Buy |
| 20-day EMA: | 24.74 | Buy |
| 50-day EMA: | 26.33 | Sell |
| 200-day EMA: | 31.02 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.39 | Buy |
| 20-day SMA: | 58.12 | Buy |
| 50-day SMA: | 63.04 | Sell |
| 200-day SMA: | 44.92 | Buy |
| 8-day EMA: | 58.53 | Buy |
| 20-day EMA: | 58.98 | Sell |
| 50-day EMA: | 59.56 | Sell |
| 200-day EMA: | 50.42 | Buy |
Unity Software Earnings Growth & U Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.05 per share, and an increase next year of $0.39 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
Unity Software Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||